Why do we age? It’s a universal process but some of the fundamental mechanisms are still surprisingly unclear. Our researchers are investigating many aspects of aging, seeking to find ways to increase healthy life, known as health span, as well as gaining a better understanding of aging-related diseases and identifying targets for new therapies.
We are one of only five institutions designated a Nathan Shock Center of Excellence in the Basic Biology of Aging by the National Institute on Aging. Laboratory researchers found the first pharmaceutical agent, rapamycin, proven to significantly lengthen lifespan in a mammal, use the latest genomics technologies to study aging-related diseases such as Alzheimer’s disease and cancer, study the underlying genetics of age-related kidney dysfunction, and much more.